You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion

  • Technology appraisal guidance
  • Reference number: TA283
  • Published:  22 May 2013
  • Last updated:  20 May 2024
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Ranibizumab for macular oedema caused by retinal vein occlusion (PDF 162 KB)

    Published:
    22 May 2013
  • Gwybodaeth i'r cyhoedd (Word 116 KB)

    Published:
    07 October 2013
Back to top